Join Our Mailing List!
Latest News:
“A Brief History of Pittsburgh Railways” -- "West Jefferson Hills Historical Society Program" -- 31 May 2025
Valley Garden Club Awards Scholarships to Local ... -- "The Valley Garden Club has awarded two $1,500 scholarships this year to worthy ..." -- 31 May 2025
2nd annual Provins-Hummel Memorial Golf Outing ... -- "Local law enforcement, military personnel, veterans, and community members came ..." -- 31 May 2025
Operation Troop Appreciation Collecting Used ... -- "Operation Troop Appreciation (OTA) Is now collecting “gently used costume ..." -- 31 May 2025
‘Music in the Park’ – Free Summer Concerts at ... -- "The City of Monessen and the Mon Valley Academy for the Arts have partnered to ..." -- 31 May 2025
Dinner Theatre Show at Long Branch Community ... -- "Long Branch Community Grange is happy to announce that Gary Lane will be ..." -- 31 May 2025
SAVE THE DATE! -- "Saints Joachim and Anne Parish Youth Group Presents ‘Cruzin’ ..." -- 31 May 2025
2nd Annual Red White & Blue 5K ‘Color Run’ in ... -- "Community Revitalization of West Newton (C.R.O.W.N.) is having their 2nd annual ..." -- 31 May 2025
West Newton Community Yard Sale List Available -- "The West Newton Community Yard Sale will be held on Saturday, June 14 ..." -- 31 May 2025
Peters Creek Historical Society Presentation on ... -- "Peters Creek Historical society welcomes Mr. Robert Stakely, director of the ..." -- 31 May 2025

Allegheny Health Network (AHN) announced recently that four of its hospitals have received the antiviral medication Remdesivir to treat hospitalized COVID-19 patients. AHN’s Allegheny Valley, Forbes, Jefferson and West Penn hospitals have each received doses of the investigational medication.

Following a clinical trial in which it was shown to shorten the recovery time in some people with COVID-19, Remdesivir has been approved by the Food and Drug Administration (FDA) for emergency use for patients on oxygen therapy or mechanical ventilation. The drug is also available to some hospitals, including AHN’s Allegheny General Hospital, as part of an expanded access treatment protocol by the drug’s manufacturer Gilead Sciences.

“As the only drug proven to be effective against COVID-19 in a rigorous trial, we are pleased to be able to treat our most critically-ill, hospitalized patients with the therapy,” said Brian Parker, MD, Chief Quality Officer, AHN.

Remdesivir, which is administered to patients through an IV, may help decrease the amount of coronavirus in a person’s body which may help them recover more quickly, says Dr. Parker.

According to the Pennsylvania Department of Health, hospitals that have received shipments of the medication were determined based on the number of COVID-19 patients at the hospital over a recent seven-day period, and the severity of the illness of those patients based on whether they are on a ventilator.

As the department acquires more doses of Remdesivir, AHN will work to obtain additional doses to serve more of its patients as needed.

RealEstate270x64

PSC 399430 HRb 

MESSENGERWEBAD

Pizza Station

 

  • Prev
  • Featured Advertisers
Scroll to top